Filing Flows › Pacific Biosciences of California (PACB) › Product revenue revenue
Pacific Biosciences of California (PACB) Product revenue revenue by quarter
Pacific Biosciences of California's Product revenue revenue was $34.0M in Q3 2026 (third quarter 2026), +3% from Q2 2026. Over the last 7 quarters it ranged from $31.1M (Q1 2025) to $39.0M (Q4 2025).
| Quarter | Product revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $34.0M | +3% | +4% |
| Q2 2026 | $33.0M | +4% | -0.4% |
| Q1 2026 | $31.5M | -19% | +1% |
| Q4 2025 | $39.0M | +20% | — |
| Q3 2025 | $32.6M | -1% | — |
| Q2 2025 | $33.1M | +6% | — |
| Q1 2025 | $31.1M | — | — |
Q3 2026 at a glance
Pacific Biosciences of California, Q3 2026: revenue $40.6M (+6% year over year), operating margin -91.2%, net loss $37.8M, operating cash flow −$37.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Pacific Biosciences of California's Product revenue revenue?
Pacific Biosciences of California's Product revenue revenue was $34.0M in Q3 2026 (third quarter 2026), +3% from Q2 2026.
How has Pacific Biosciences of California's Product revenue revenue changed?
Over the last 7 quarters it ranged from $31.1M (Q1 2025) to $39.0M (Q4 2025).
Q3 2026 results → · How Pacific Biosciences of California makes money →